Skip to main content

Peer Review reports

From: Establishment of canine mammary gland tumor cell lines harboring PI3K/Akt activation as a therapeutic target

Original Submission
9 Jun 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Aug 2023 Author responded Author comments - Sung-Hak Kim
Resubmission - Version 3
23 Aug 2023 Submitted Manuscript version 3
6 Nov 2023 Reviewed Reviewer Report
7 Nov 2023 Reviewed Reviewer Report - Hong Zhang
7 Feb 2024 Author responded Author comments - Sung-Hak Kim
Resubmission - Version 4
7 Feb 2024 Submitted Manuscript version 4
12 Feb 2024 Author responded Author comments - Sung-Hak Kim
Resubmission - Version 5
12 Feb 2024 Submitted Manuscript version 5
28 Feb 2024 Reviewed Reviewer Report - Hong Zhang
4 Mar 2024 Reviewed Reviewer Report
18 Apr 2024 Author responded Author comments - Sung-Hak Kim
Resubmission - Version 6
18 Apr 2024 Submitted Manuscript version 6
26 Apr 2024 Author responded Author comments - Sung-Hak Kim
Resubmission - Version 7
26 Apr 2024 Submitted Manuscript version 7
3 May 2024 Author responded Author comments - Sung-Hak Kim
Resubmission - Version 8
3 May 2024 Submitted Manuscript version 8
11 May 2024 Author responded Author comments - Sung-Hak Kim
Resubmission - Version 9
11 May 2024 Submitted Manuscript version 9
Publishing
16 May 2024 Editorially accepted
29 May 2024 Article published 10.1186/s12917-024-04085-w

You can find further information about peer review here.

Back to article page